The Scientist

» Roger Tsien

Most Recent

image: Those We Lost in 2016

Those We Lost in 2016

By | December 23, 2016

The scientific community bid farewell to several luminaries this year.

1 Comment

image: Electron Micrographs Get a Dash of Color

Electron Micrographs Get a Dash of Color

By | November 3, 2016

A new technique creates colorful stains that label proteins and cellular structures at higher resolution than ever before possible. 

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | October 1, 2016

Roger Tsien R.I.P., predatory publishing, and diversity in science

0 Comments

image: Week in Review: August 29–September 2

Week in Review: August 29–September 2

By | September 2, 2016

Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

0 Comments

image: Nobel Laureate Roger Tsien Dies

Nobel Laureate Roger Tsien Dies

By | August 31, 2016

One of the pioneers in developing fluorescent proteins for biological studies was 64 years old.

1 Comment

image: Speaking of Science

Speaking of Science

By | May 1, 2013

May 2013's selection of notable quotes

3 Comments

image: What Ever Happened to Douglas Prasher?

What Ever Happened to Douglas Prasher?

By | February 26, 2013

The first researcher to clone the gene for green fluorescent protein, but who was passed over for the 2008 Nobel Prize in Chemistry, is back in academic science.

9 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham